Impact of Pharmacy-Led Dyslipidemia Interventions on Medication Safety and Therapeutic Failure in Patients
AGENCY FOR HEALTHCARE RESEARCH AND QUALITY ROCKVILLE MD
Pagination or Media Count:
The researchers sought to assess the impact of pharmacologic intervention on previously identified patients with coronary heart disease CHD, diabetes, or multiple risk factors who experienced therapeutic failure in treating hyperlipidemia. The study also sought to evaluate changes in medication usage patterns, including rates of unsafe combination therapies before versus after the interventions, and reevaluate the analyses of barriers to effective treatment, including safety concerns.
- Medicine and Medical Research